ADORA2B and acute respiratory distress syndrome: Although further studies are needed to understand how calpain is activated by hypoxia, and which calpain is directed targeted by adora2b/PKA, our findings identified calpain as a novel downstream target of Adora2b and provide evidence for the development of drugs aimed at targeting adenosine signaling and calpain as a therapeutic treatment of ALI.